波多野结衣av在线免费,国产偷国产偷亚洲高清人

Traxanox sodium

NMR下載 COA and HPLC MSDS下載
names：
5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt
CAS號(hào)：
70502-82-8
MDL Number：
MF(分子式)： C13H5ClN5NaO2 MW(分子量)： 321.6558
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫存描述	數(shù)量	總計(jì) (￥)

大包裝詢價(jià) 提供各種包裝，敬請垂詢
收藏商品商品點(diǎn)評加入購物車立即購買

快速詢價(jià)

收起

你想詢價(jià)的產(chǎn)品

*產(chǎn)品名稱：

CAS號(hào)：

產(chǎn)品編號(hào)：

需求描述：

請準(zhǔn)確填寫您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱：

*電子郵箱：

聯(lián)系人：

*電話：

*驗(yàn)證碼：

詢價(jià)

中文別名	5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt
英文別名	Traxanox sodium; Y 12141; Y-12141; Y12141.
CAS號(hào)	70502-82-8
Inchi	InChI=1S/C13H5ClN5O2.Na/c14-9-5-6(12-16-18-19-17-12)4-8-10(20)7-2-1-3-15-13(7)21-11(8)9;/h1-5H;/q-1;+1
InchiKey	LAEVCGNXDKGJQI-UHFFFAOYSA-N
分子式 Formula	C13H5ClN5NaO2
分子量 Molecular Weight	321.6558
溶解度Solubility
性狀	Solid powder
儲(chǔ)藏條件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

產(chǎn)品說明	Traxanox sodium(CAS:70502-82-8):僅限應(yīng)用于工業(yè)或者科學(xué)研究過程中非醫(yī)療目的，不應(yīng)用于人類或動(dòng)物的臨床診斷以及治過程療，該產(chǎn)品非藥用，非食用。
Introduction	Traxanox sodium is a biochemical.
Application1
Application2
Application3

警示圖
危險(xiǎn)性	Warning
危險(xiǎn)性警示
安全聲明
安全防護(hù)
備注

[1]Fujimura A, Ebihara A, Hino N, Koike Y. Effects of traxanox sodium on blood pressure and serum uric acid in hypertensive patients: a preliminary study. J Clin Pharmacol. 1989 Apr;29(4):327-30. PubMed PMID: 2723121.

[2]Hisadome M, Terasawa M, Goto K, Kawazoe Y, Okumoto T. Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats. Jpn J Pharmacol. 1989 Feb;49(2):275-84. PubMed PMID: 2733265.

[3] Terasawa M, Tomomatsu N, Maruyama Y. [Effects of traxanox sodium on experimental nasal allergy]. Nihon Yakurigaku Zasshi. 1988 Jul;92(1):11-6. Japanese. PubMed PMID: 3220322.

[4] Ebihara A, Tsuru M, Ohashi K, Fujimura A, Kondo K. Diuretic and uricosuric effects of traxanox sodium in healthy subjects. Single dose study. Arzneimittelforschung. 1987 Dec;37(12):1388-91. PubMed PMID: 3329516.

[5] Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol. 1987 Feb;90(2):421-9. PubMed PMID: 2435353; PubMed Central PMCID: PMC1916952.

6: Terasawa M, Imayoshi T, Maruyama Y, Abe C. [Effect of traxanox sodium on inflammatory response]. Nihon Yakurigaku Zasshi. 1985 Nov;86(5):329-40. Japanese. PubMed PMID: 2867959.7: Terasawa M, Imayoshi T, Goto K. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):93-101. Japanese. PubMed PMID: 6194083.8: Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):79-92. Japanese. PubMed PMID: 6137441.9: Goto K, Osuga K, Haga K, Tsumagari T. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system]. Nihon Yakurigaku Zasshi. 1983 May;81(5):343-63. Japanese. PubMed PMID: 6629211.10: Ikegami K, Hirano S, Hasegawa G. The effects of traxanox sodium of cyclic AMP phosphodiesterase and the concentration of cyclic AMP in the plasma of rats. Chem Pharm Bull (Tokyo). 1983 Feb;31(2):752-5. PubMed PMID: 6309423.1

對不起，暫無產(chǎn)品評價(jià)！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開